InvestorsHub Logo
Followers 0
Posts 412
Boards Moderated 0
Alias Born 08/05/2016

Re: None

Tuesday, 09/12/2017 8:37:46 AM

Tuesday, September 12, 2017 8:37:46 AM

Post# of 108192
James, since you seem to be the most respected one here I'd like to get your opinion. Do you have any idea why ADXS is dropping HER2? I see the clinical trial says its still recruiting but guess it just hasn't been updated yet. I'm especially curious why they are stopping since it has been fast tracked. This just came out of the blue. To me, ADXS simply saying they are making a "portfolio rfefinement" is not a good answer. Companies don't just drop good products for no reason. So I am wondering what the reason could be? Could it be because they are low on money and it's too costly? Or could it be because they have results that are not good? But in that case I think they would have to release those results. It's baffling. I know you have common sense and won't give a ridiculous answer, like someone else here, that they are not pursuing because the company they are in negotiations with for a buyout doesn't want HER2. This whole thing just seems odd to me.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News